Literature DB >> 10327277

Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies.

M F Linton1, S Fazio.   

Abstract

The macrophage expresses a variety of genes that may contribute to lipoprotein metabolism and atherosclerotic lesion formation. Bone marrow transplantation experiments using gene-targeted mice, both as donors and recipients, provide a useful approach to examine the contribution of macrophage gene expression to lipoprotein metabolism and atherogenesis in vivo. This article describes recent insights into the role of macrophage expression of apolipoprotein E and the LDL receptor gained from bone marrow transplantation studies in the mouse.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327277     DOI: 10.1097/00041433-199904000-00003

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  15 in total

1.  Identification of macrophage liver X receptors as inhibitors of atherosclerosis.

Authors:  Rajendra K Tangirala; Eric D Bischoff; Sean B Joseph; Brandee L Wagner; Robert Walczak; Bryan A Laffitte; Chris L Daige; Diane Thomas; Richard A Heyman; David J Mangelsdorf; Xuping Wang; Aldons J Lusis; Peter Tontonoz; Ira G Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

2.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.

Authors:  Kyriakos E Kypreos; Vassilis I Zannis
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

3.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

4.  Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

Authors:  Hagai Tavori; Yan Ru Su; Patricia G Yancey; Ilaria Giunzioni; Ashley J Wilhelm; John L Blakemore; Manal Zabalawi; MacRae F Linton; Mary G Sorci-Thomas; Sergio Fazio
Journal:  J Lipid Res       Date:  2015-01-15       Impact factor: 5.922

Review 5.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

6.  Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.

Authors:  Hagai Tavori; Daping Fan; Ilaria Giunzioni; Lin Zhu; MacRae F Linton; Agnes B Fogo; Sergio Fazio
Journal:  J Lipid Res       Date:  2014-09-02       Impact factor: 5.922

7.  Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.

Authors:  Manabu Takahashi; Hiroaki Yagyu; Fumiko Tazoe; Shuichi Nagashima; Taichi Ohshiro; Kenta Okada; Jun-ichi Osuga; Ira J Goldberg; Shun Ishibashi
Journal:  J Lipid Res       Date:  2013-02-03       Impact factor: 5.922

8.  Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.

Authors:  Zengxuan Nong; Herminia Gonzalez-Navarro; Marcelo Amar; Lita Freeman; Catherine Knapper; Edward B Neufeld; Beverly J Paigen; Robert F Hoyt; Jamila Fruchart-Najib; Silvia Santamarina-Fojo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein.

Authors:  Konstantinos Drosatos; Kyriakos E Kypreos; Vassilis I Zannis
Journal:  Biochemistry       Date:  2007-07-27       Impact factor: 3.162

10.  A practical approach to using mice in atherosclerosis research.

Authors:  Stewart C Whitman
Journal:  Clin Biochem Rev       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.